Literature DB >> 2260915

Effect of estrogens on prolactin secretion in transsexual subjects.

H H Goh1, S S Ratnam.   

Abstract

The effect of estrogens on the secretion of prolactin in 8 different groups of transsexual subjects was studied. Two different types of estrogens, estradiol or its conjugate and ethinyl estradiol, were used. Different doses and durations of exposure were employed. Plasma levels of prolactin and SHBG after estrogen exposure were compared with corresponding levels before treatment. Results showed that for estrogens to exert an enhancing effect on the secretion of prolactin, three factors needed to be considered: (i) the absolute concentration of estrogen, (ii) the duration of exposure, and (iii) whether levels of SHBG are sufficiently altered to change the concentration of free estrogen. It appears that there exist both time and dose thresholds for effective enhancement of prolactin secretion by estrogen. Estradiol and its conjugate are more likely to induce hyperprolactinemia than ethinyl estradiol. The reduced effect of the latter is probably related to its ability to induce large and rapid increases in SHBG binding which probably results in unaltered free estrogen concentration. In the light of this study, treatment of male transsexuals with high doses of estradiol in its conjugate forms must be viewed with caution.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2260915     DOI: 10.1007/bf02442351

Source DB:  PubMed          Journal:  Arch Sex Behav        ISSN: 0004-0002


  12 in total

Review 1.  Regulation of prolactin secretion by oestrogens: physiological and pathological significance.

Authors:  S Franks
Journal:  Clin Sci (Lond)       Date:  1983-11       Impact factor: 6.124

2.  Testosterone-binding levels in the serum of women during the normal menstrual cycle, pregnancy, and the post-partum period.

Authors:  W H Pearlman; O Crépy; M Murphy
Journal:  J Clin Endocrinol Metab       Date:  1967-07       Impact factor: 5.958

3.  Oral contraceptive history as a risk indicator in patients with pituitary tumors with hyperprolactinemia: a case comparison study of twenty patients.

Authors:  L Teperman; W Futterweit; R Zappulla; L I Malis
Journal:  Neurosurgery       Date:  1980-12       Impact factor: 4.654

4.  Effects of large doses of estrogen on prolactin and growth hormone release.

Authors:  Y Ehara; T M Siler; S S Yen
Journal:  Am J Obstet Gynecol       Date:  1976-06-15       Impact factor: 8.661

5.  Follow-up of prolactin levels in long-term oestrogen-treated male-to-female transsexuals with regard to prolactinoma induction.

Authors:  L J Gooren; W Harmsen-Louman; H van Kessel
Journal:  Clin Endocrinol (Oxf)       Date:  1985-02       Impact factor: 3.478

6.  Pathogenesis of prolactin-secreting pituitary adenomas.

Authors:  B M Sherman; C E Harris; J Schlechte; T M Duello; N S Halmi; J VanGilder; F K Chapler; D K Granner
Journal:  Lancet       Date:  1978-11-11       Impact factor: 79.321

7.  Oral contraceptive use and the occurrence of pituitary prolactinoma.

Authors:  K K Shy; A M McTiernan; J R Daling; N S Weiss
Journal:  JAMA       Date:  1983 Apr 22-29       Impact factor: 56.272

8.  Prolactin levels and pituitary enlargement in hormone-treated male-to-female transsexuals.

Authors:  H Asscheman; L J Gooren; J Assies; J P Smits; R de Slegte
Journal:  Clin Endocrinol (Oxf)       Date:  1988-06       Impact factor: 3.478

9.  Control of gonadotrophin secretion by steroid hormones in castrated male transsexuals. I. Effects of oestradiol infusion on plasma levels of follicle-stimulating hormone and luteinizing hormone.

Authors:  H H Goh; P C Chew; S M Karim; S S Ratnam
Journal:  Clin Endocrinol (Oxf)       Date:  1980-02       Impact factor: 3.478

10.  Oestrogen-related changes in sex hormone binding globulin levels during normal and gonadotrophin-stimulated menstrual cycles.

Authors:  M Dowsett; S L Attree; S S Virdee; S L Jeffcoate
Journal:  Clin Endocrinol (Oxf)       Date:  1985-09       Impact factor: 3.478

View more
  1 in total

Review 1.  What can we learn from rodents about prolactin in humans?

Authors:  Nira Ben-Jonathan; Christopher R LaPensee; Elizabeth W LaPensee
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.